CD4 Protein

CD4 Protein

Pathway Diagram

```mermaid
flowchart TD
CD4["CD4<br/>T-helper cell receptor"]

CD4 -->|"regulates"| Neurodegeneration["Neurodegeneration<br/>Process"]
CD4 -->|"activates"| MS["Multiple Sclerosis<br/>Autoimmune demyelination"]
CD4 -->|"inhibits"| ALS["Amyotrophic Lateral Sclerosis<br/>Motor neuron disease"]
CD4 -->|"regulates"| PD["Parkinson's Disease<br/>Dopaminergic degeneration"]
CD4 -->|"regulates"| Dementia["Dementia<br/>Cognitive decline"]

CD4 -->|"regulates"| Inflammation["Neuroinflammation<br/>Immune activation"]
CD4 -->|"regulates"| Autoimmune["Autoimmune Response<br/>Self-reactive immunity"]

Inflammation -->|"promotes"| Neurodegeneration
Inflammation -->|"contributes_to"| MS
Inflammation -->|"damages"| PD

Autoimmune -->|"drives"| MS
Autoimmune -->|"influences"| Neurodegeneration

CD4 -->|"activates"| Aging["Cellular Aging<br/>Senescence processes"]
Aging -->|"accelerates"| Neurodegeneration
Aging -->|"increases_risk"| Dementia

CD4 -->|"therapeutic_target"| MS_Treatment["MS Therapeutics<br/>Immunomodulation"]
CD4 -->|"therapeutic_target"| Neuro_Treatment["Neurodegeneration<br/>Therapeutics"]
CD4 -->|"biomarker_for"| ALS_Diagnosis["ALS Biomarker<br/>Disease monitoring"]

style CD4 fill:#006494
style MS_Treatment fill:#1b5e20
style Neuro_Treatment fill:#1b5e20
style ALS_Diagnosis fill:#1b5e20
style MS fill:#ef5350
style ALS fill:#ef5350
style Neurodegeneration fill:#ef5350
style Inflammation fill:#ef5350
sty

CD4 Protein

Pathway Diagram

Introduction

Cd4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e74c3c;color:white;text-align:center">CD4</th></tr>
<tr><th>Gene</th><td>[CD4](/genes/cd4)</td></tr>
<tr><th>UniProt ID</th><td>[P01730](https://www.uniprot.org/uniprotkb/P01730)</td></tr>
<tr><th>PDB ID</th><td>1WIP, 1WIO, 2KLU</td></tr>
<tr><th>Molecular Weight</th><td>55 kDa</td></tr>
<tr><th>Subcellular Localization</th><td>Plasma membrane (T cell surface), intracellular pools</td></tr>
<tr><th>Protein Family</th><td>Immunoglobulin superfamily, T cell receptor complex</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, HIV-Associated Neurocognitive Disorder</td></tr>
</table>
</div>

Overview

CD4 is a glycoprotein receptor expressed primarily on the surface of T helper cells, regulatory T cells, and monocytes. While classically known for its role in adaptive immunity as a co-receptor for the T cell receptor (TCR), recent research has revealed important functions in the central nervous system where it is expressed on [microglia](/entities/microglia) and certain neuronal populations. CD4-mediated signaling has implications for neuroinflammation, neurodegeneration, and autoimmune responses in the brain.

Structure

CD4 is a single-pass transmembrane glycoprotein consisting of:

• Extracellular domain: Four immunoglobulin-like domains (D1-D4)
• D1: MHC class II binding domain
• D2-D4: Supportive immunoglobulin folds
• Transmembrane domain: Single α-helical segment anchoring CD4 in the plasma membrane
• Cytoplasmic tail: Contains signaling motifs including:
• LCK binding site (Cys-X-Cys motif)
• PKC phosphorylation sites
• ITIM (Immunoreceptor Tyrosine-based Inhibition Motif) in certain contexts

Normal Function

T Cell Biology

• Co-receptor for MHC class II presentation to TCR
• Enhances TCR signaling strength and specificity
• Recruits LCK kinase to the TCR complex
• Essential for T helper cell activation and differentiation
• Maintains T cell tolerance and regulatory function

CNS Expression and Function

• Expressed on [microglia](/cell-types/microglia-neuroinflammation) in the brain and spinal cord
• Modulates microglial activation states
• Involved in synaptic pruning during development
• Regulates neuroinflammatory responses to injury

Role in Disease

Alzheimer's Disease

• CD4+ T cells accumulate in AD brain tissue
• Dysregulated CD4+ T cell responses contribute to chronic neuroinflammation
• Th1/Th17 polarization promotes [Aβ](/proteins/amyloid-beta)-driven inflammation
• Regulatory T cell dysfunction impairs clearance of pathological proteins
• CD4+ T cell-derived cytokines influence microglial activation

Parkinson's Disease

• CD4+ T cell infiltration observed in substantia nigra
• Pro-inflammatory CD4+ T cells contribute to dopaminergic neuron death
• Regulatory T cells may provide neuroprotective effects
• [α-Synuclein](/proteins/alpha-synuclein)-specific T cell responses documented in PD patients

Multiple Sclerosis

• CD4+ T cells are primary effectors in demyelination
• Th1 and Th17 cells drive autoimmune attack on myelin
• Therapeutic strategies target CD4+ T cell activation
• Regulatory T cell therapy shows promise in MS models

HIV-Associated Neurocognitive Disorder (HAND)

• HIV infection depletes CD4+ T cells systemically
• Neuroinflammation persists despite viral suppression
• CD4+ T cell dysfunction contributes to cognitive impairment
• Microglial activation driven by loss of CD4+ T cell regulation

Neuroinflammation

• CD4+ T cells orchestrate inflammatory responses in CNS
• Cytokine release (IFN-γ, TNF-α, IL-17) activates microglia
• [Blood-brain barrier](/entities/blood-brain-barrier) disruption facilitates T cell entry
• Balance between pro-inflammatory and regulatory CD4+ T cells is critical

Therapeutic Targeting

Immunomodulatory Approaches

• CD4-directed antibodies: Used in autoimmune conditions, potential for neuroinflammation
• Regulatory T cell therapy: Expand autologous Tregs for neuroprotection
• IL-2 therapy: Low-dose IL-2 expands Tregs
• JAK inhibitors: Block CD4+ T cell signaling pathways

Disease-Modifying Strategies

• Natalizumab: α4-integrin blocker, prevents T cell CNS entry (for MS)
• Fingolimod: S1P receptor modulator, traps T cells in lymph nodes
• Alemtuzumab: CD52 antibody, depletes T and B cells

Neurodegeneration Applications

• Targeting CD4+ T cell-mediated inflammation in AD/PD
• Enhancing regulatory T cell function
• Blocking pro-inflammatory Th1/Th17 differentiation
• Modulating microglial activation through CD4 signaling

Key Publications

Background

The study of Cd4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Reinherz EL, et al (1989). Crystal structure of the CD4 immunoglobulin-like domain. Science. 246(4935):1339-1342. PMID: 2538927(https://pubmed.ncbi.nlm.nih.gov/2538927/).

Mosmann TR, et al (1986). Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 136(7):2348-2357. PMID: 2419430(https://pubmed.ncbi.nlm.nih.gov/2419430/).

Sutton CE, et al (2009). Interleukin-1 and IL-23 induce innate IL-17A responses from Th17 cells. Nat Rev Immunol. 9(5):314-328. PMID: 18408734(https://pubmed.ncbi.nlm.nih.gov/18408734/).

Liu G, et al (2020). CD4+ T cell-mediated neuroinflammation in Alzheimer's disease. Cell Mol Neurobiol. 40(7):1077-1089. PMID: 32052341(https://pubmed.ncbi.nlm.nih.gov/32052341/).

See Also

• CD4 Gene
• T Cells and Neurodegeneration
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Multiple Sclerosis](/diseases/multiple-sclerosis)
• [Microglia](/cell-types/microglia)
• [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)

External Links

• [UniProt P01730](https://www.uniprot.org/uniprotkb/P01730)
• [PDB: 1WIP](https://www.rcsb.org/structure/1WIP)
• [CD4 Immunology - Immunology Wiki](https://en.wikipedia.org/wiki/CD4)